CTOR
Price
$0.56Alerts
Change
-$0.00 (-0.00%)
Updated
Nov 11 closing price
Capitalization
53.88M
40 days until earnings call
Intraday BUY SELL Signals
PRGO
Price
$16.55Alerts
Change
-$0.28 (-1.66%)
Updated
Nov 11, 04:59 PM (EDT)
Capitalization
2.2B
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CTOR vs PRGO

CTOR vs PRGO Comparison Chart in %
View a ticker or compare two or three
VS
CTOR vs. PRGO commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTOR is a StrongBuy and PRGO is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CTOR with price predictions
Nov 11, 2026

CTOR's RSI Indicator ascends from oversold territory

The RSI Oscillator for CTOR moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 13 similar instances when the indicator left oversold territory. In 12 of the 13 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 24 of 42 cases where CTOR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 57%.

The Moving Average Convergence Divergence (MACD) for CTOR just turned positive on November 10, 2026. Looking at past instances where CTOR's MACD turned positive, the stock continued to rise in 16 of 36 cases over the following month. The odds of a continued upward trend are 44%.

Following a +10.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where CTOR advanced for three days, in 93 of 117 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

CTOR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

CTOR moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CTOR crossed bearishly below the 50-day moving average on October 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

The 50-day moving average for CTOR moved below the 200-day moving average on November 03, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTOR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for CTOR entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 30 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.334) is normal, around the industry mean (6.379). P/E Ratio (-1.061) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (12.547) is also within normal values, averaging (183.387).

The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. CTOR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTOR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for PRGO with price predictions
Nov 11, 2026

PRGO's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Indicator for PRGO moved out of overbought territory on November 10, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 instances where the indicator moved out of the overbought zone. In 26 of the 31 cases the stock moved lower in the days that followed. This puts the odds of a move down at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PRGO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

PRGO broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 09, 2026. You may want to consider a long position or call options on PRGO as a result. In 58 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.

The Moving Average Convergence Divergence (MACD) for PRGO just turned positive on November 10, 2026. Looking at past instances where PRGO's MACD turned positive, the stock continued to rise in 26 of 42 cases over the following month. The odds of a continued upward trend are 62%.

Following a +7.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where PRGO advanced for three days, in 179 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

The Aroon Indicator entered an Uptrend today. In 120 of 204 cases where PRGO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 59%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.874) is normal, around the industry mean (6.379). P/E Ratio (-1.266) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (1.142) is also within normal values, averaging (2.202). Dividend Yield (0.073) settles around the average of (0.062) among similar stocks. P/S Ratio (0.454) is also within normal values, averaging (183.387).

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. PRGO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 90 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PRGO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
PRGO: Fundamental Ratings
PRGO
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
20

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTORPRGO
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
57%
Bearish Trend 1 day ago
71%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
65%
MACD
ODDS (%)
Bullish Trend 1 day ago
44%
Bullish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
48%
Bullish Trend 1 day ago
65%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 3 days ago
64%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 1 day ago
67%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
59%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (CTOR: $0.56 vs. PRGO: $16.55)
Brand notoriety: CTOR and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CTOR: 46% vs. PRGO: 49%
Market capitalization -- CTOR: $53.88M vs. PRGO: $2.2B
CTOR [@Pharmaceuticals: Generic] is valued at $53.88M. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $2.2B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTOR’s FA Score shows that 1 FA rating(s) are green while PRGO’s FA Score has 1 green FA rating(s).

  • CTOR’s FA Score: 1 green, 4 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, both CTOR and PRGO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTOR’s TA Score shows that 4 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • CTOR’s TA Score: 4 bullish, 5 bearish.
  • PRGO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRGO is a better buy in the short-term than CTOR.

Price Growth

CTOR (@Pharmaceuticals: Generic) experienced а +2.31% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was +4.55% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.20%. For the same industry, the average monthly price growth was -6.54%, and the average quarterly price growth was +10.31%.

Reported Earning Dates

CTOR is expected to report earnings on Dec 22, 2026.

PRGO is expected to report earnings on Mar 01, 2027.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.20% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
Interact to see
Advertisement

CTOR and

Correlation & Price change

A.I.dvisor tells us that CTOR and BFRI have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTOR and BFRI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTOR
1D Price
Change %
CTOR100%
-0.71%
BFRI - CTOR
25%
Poorly correlated
+1.02%
PRGO - CTOR
25%
Poorly correlated
-1.66%
IMCC - CTOR
22%
Poorly correlated
-6.05%
RDHL - CTOR
21%
Poorly correlated
-2.43%
HIMS - CTOR
21%
Poorly correlated
+8.78%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with SUPN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-1.66%
SUPN - PRGO
49%
Loosely correlated
+2.43%
ELAN - PRGO
37%
Loosely correlated
-1.05%
EVO - PRGO
35%
Loosely correlated
N/A
ALVO - PRGO
34%
Loosely correlated
+0.82%
TAK - PRGO
31%
Poorly correlated
-0.43%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SCLZ55.760.74
+1.35%
Swan Enhanced Dividend Income ETF (SCLZ)
XOEX41.320.37
+0.91%
Xtrackers S&P 100 Ex Top 20 ETF (XOEX)
KYC26.550.20
+0.78%
Corgi Digital Banking & Fintech Infrastructure ETF (KYC)
RFDA72.450.46
+0.64%
ALPS Dynamic US Dividend Advantage ETF (RFDA)
CERY37.400.23
+0.62%
State Street SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF (CERY)